Literature DB >> 11204826

Art of replacing craniofacial bone defects.

D K Rah1.   

Abstract

In the history of medicine, many surgeons have been tried to reconstruct lost tissue and correct deformity, attempts to use implant materials have probably paralleled those involving autogenous tissue. Recently there has been an acceleration in the understanding of the requirements and potentials of implant materials caused by collaboration between material scientists, biomaterials engineers, clinicians, and clinical investigators. Alloplastic materials have become an essential part of reconstructing the function and contour of the craniofacial skeleton. Bone is a specialized form of connective tissue, which provides support, and protects vital and delicate organs. Bone is embryologically derived from mesenchymal tissue through membranous and endochondral ossification. In the clinical field, the need for bone graft has been increased due to trauma, tumor, craniosynostosis, and pure esthetic bone surgery. Various types of bone grafts have been used to repair craniofacial bone defects over many years, but the autogenous graft has many disadvantages, such as, limited donor sites, donor morbidity, pain, growth deformity and resorption. Many surgeons working in a number of centers around the world have created substitutes and simpler methods for bone replacement. As the alloplatic bone substitute has been advanced, many synthetic substitutes are replaced by bone in vivo over time. The ideal material should be cost effective, non-toxic, non-antigenic, non-carcinogenic, and inert in the body fluids, be easily shaped at the operating table, and maintain its desired form and consistency in situ. This article reviews several of the more commonly used materials for craniofacial reconstruction and summarizes their mechanical properties and clinical aspects.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11204826     DOI: 10.3349/ymj.2000.41.6.756

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  9 in total

Review 1.  Craniofacial tissue engineering by stem cells.

Authors:  J J Mao; W V Giannobile; J A Helms; S J Hollister; P H Krebsbach; M T Longaker; S Shi
Journal:  J Dent Res       Date:  2006-11       Impact factor: 6.116

2.  Basic fibroblast growth factor inhibits osteogenic differentiation of stem cells from human exfoliated deciduous teeth through ERK signaling.

Authors:  B Li; C Qu; C Chen; Y Liu; K Akiyama; R Yang; F Chen; Y Zhao; S Shi
Journal:  Oral Dis       Date:  2011-12-12       Impact factor: 3.511

3.  Sutures Possess Strong Regenerative Capacity for Calvarial Bone Injury.

Authors:  Shery Park; Hu Zhao; Mark Urata; Yang Chai
Journal:  Stem Cells Dev       Date:  2016-10-24       Impact factor: 3.272

4.  Osteogenic differentiation of mesenchymal stem cells on pregenerated extracellular matrix scaffolds in the absence of osteogenic cell culture supplements.

Authors:  Richard A Thibault; L Scott Baggett; Antonios G Mikos; F Kurtis Kasper
Journal:  Tissue Eng Part A       Date:  2010-02       Impact factor: 3.845

5.  Computer-aided design and rapid prototyping-assisted contouring of costal cartilage graft for facial reconstructive surgery.

Authors:  Shu Jin Lee; Heow Pueh Lee; Kwong Ming Tse; Ee Cherk Cheong; Siak Piang Lim
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2012-06

6.  Scaffold/Extracellular matrix hybrid constructs for bone-tissue engineering.

Authors:  Richard A Thibault; Antonios G Mikos; F Kurtis Kasper
Journal:  Adv Healthc Mater       Date:  2012-09-28       Impact factor: 9.933

7.  Small molecule inhibitor of TGF-β signaling enables robust osteogenesis of autologous GMSCs to successfully repair minipig severe maxillofacial bone defects.

Authors:  Anyuan Shi; Aerali Heinayati; Dongyu Bao; Huifen Liu; Xiaochen Ding; Xin Tong; Liudi Wang; Bin Wang; Haiyan Qin
Journal:  Stem Cell Res Ther       Date:  2019-06-13       Impact factor: 6.832

8.  Effects of polycaprolactone-tricalcium phosphate, recombinant human bone morphogenetic protein-2 and dog mesenchymal stem cells on bone formation: pilot study in dogs.

Authors:  Sun-Jong Kim; Myung-Rae Kim; Jin-Sub Oh; Inho Han; Sang-Wan Shin
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

9.  Small Molecule Inhibition of Transforming Growth Factor Beta Signaling Enables the Endogenous Regenerative Potential of the Mammalian Calvarium.

Authors:  Kshemendra Senarath-Yapa; Shuli Li; Graham G Walmsley; Elizabeth Zielins; Kevin Paik; Jonathan A Britto; Agamemnon E Grigoriadis; Derrick C Wan; Karen J Liu; Michael T Longaker; Natalina Quarto
Journal:  Tissue Eng Part A       Date:  2016-04-26       Impact factor: 3.845

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.